Stock listing
Lang & Schwarz:A2JNDN SoftOx Solutions AS Aktie
German listing (Lang & Schwarz) of SoftOx Solutions AS · home listing Oslo:SOFTX
Follow SoftOx Solutions AS into a list and get an email when it puts out news.
Home listing price · OSL:SOFTX
0.10 NOK -0.01 (-9.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OSL:SOFTX
- Day range
- 0.099 – 0.109 NOKNov 20, 2026
- Volume
- 11.04M sharesNov 20, 2026
- Market cap
- 266.0M NOKAt the close on Nov 20, 2026 · price × 2.66B shares outstanding
- 52-week range
- 0.049 – 0.166 NOKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 2.74M NOKMedian day 13.92M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Oslo:SOFTX · Home | 0.10 NOK | -0.01 (-9.1%) | 11,038,370 | 0.109 | 0.109 | 0.099 | 0.11 | Close on Nov 20, 2026 |
| Frankfurt:6FV | €0.01 EUR | 0.00 (0.0%) | — | €0.01 | €0.01 | €0.01 | €0.01 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OSL:SOFTX · NOK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 0.10 | -0.01 | -9.1% | 0.109 | 0.109 | 0.099 | 11,038,370 | |
| 0.11 | +0.009 | +8.5% | 0.106 | 0.117 | 0.101 | 10,669,934 | |
| 0.101 | -0.002 | -1.9% | 0.10 | 0.105 | 0.10 | 3,158,095 | |
| 0.103 | +0.002 | +1.8% | 0.099 | 0.104 | 0.099 | 4,962,958 | |
| 0.102 | +0.00 | +0.4% | 0.101 | 0.103 | 0.099 | 5,607,103 | |
| 0.101 | +0.001 | +1.2% | 0.104 | 0.104 | 0.099 | 4,287,014 | |
| 0.10 | +0.002 | +1.6% | 0.097 | 0.104 | 0.097 | 8,947,604 | |
| 0.098 | -0.002 | -2.4% | 0.097 | 0.10 | 0.097 | 11,932,865 | |
| 0.101 | +0.001 | +1.3% | 0.102 | 0.103 | 0.098 | 6,882,990 | |
| 0.10 | -0.002 | -2.5% | 0.10 | 0.103 | 0.097 | 13,763,822 | |
| 0.102 | -0.002 | -2.3% | 0.102 | 0.105 | 0.10 | 9,981,613 | |
| 0.104 | +0.003 | +3.0% | 0.108 | 0.108 | 0.101 | 7,976,938 | |
| 0.101 | -0.004 | -4.0% | 0.11 | 0.11 | 0.101 | 8,771,885 | |
| 0.106 | -0.002 | -2.2% | 0.108 | 0.108 | 0.103 | 8,408,416 | |
| 0.108 | -0.003 | -2.5% | 0.11 | 0.111 | 0.105 | 12,186,040 | |
| 0.111 | -0.004 | -3.5% | 0.115 | 0.115 | 0.11 | 11,765,197 | |
| 0.115 | +0.005 | +4.6% | 0.109 | 0.12 | 0.109 | 49,115,020 | |
| 0.11 | +0.001 | +0.7% | 0.107 | 0.115 | 0.107 | 20,549,944 | |
| 0.109 | -0.002 | -1.6% | 0.11 | 0.11 | 0.106 | 11,389,198 | |
| 0.111 | -0.003 | -2.6% | 0.111 | 0.114 | 0.109 | 9,573,851 | |
| 0.114 | -0.001 | -1.0% | 0.116 | 0.116 | 0.11 | 10,855,700 | |
| 0.115 | 0.00 | 0.0% | 0.118 | 0.118 | 0.111 | 17,322,893 | |
| 0.115 | -0.004 | -3.7% | 0.12 | 0.12 | 0.113 | 13,265,366 | |
| 0.119 | +0.006 | +5.7% | 0.113 | 0.121 | 0.113 | 23,833,164 | |
| 0.113 | -0.002 | -1.6% | 0.117 | 0.12 | 0.113 | 19,705,946 | |
| 0.115 | -0.001 | -0.9% | 0.115 | 0.116 | 0.11 | 23,435,309 | |
| 0.116 | +0.004 | +3.9% | 0.115 | 0.116 | 0.112 | 10,448,703 | |
| 0.111 | -0.006 | -4.8% | 0.115 | 0.117 | 0.111 | 18,590,147 | |
| 0.117 | -0.002 | -1.8% | 0.122 | 0.124 | 0.115 | 14,805,985 | |
| 0.119 | -0.006 | -5.1% | 0.125 | 0.126 | 0.117 | 23,306,195 | |
| 0.126 | -0.001 | -0.9% | 0.13 | 0.13 | 0.111 | 109,392,592 | |
| 0.127 | -0.002 | -1.2% | 0.128 | 0.131 | 0.125 | 77,903,234 | |
| 0.128 | +0.00 | +0.3% | 0.127 | 0.129 | 0.126 | 14,986,401 | |
| 0.128 | -0.002 | -1.4% | 0.127 | 0.13 | 0.125 | 22,888,022 | |
| 0.13 | 0.00 | -0.2% | 0.128 | 0.131 | 0.127 | 29,643,299 | |
| 0.13 | +0.001 | +0.9% | 0.128 | 0.13 | 0.123 | 40,660,190 | |
| 0.129 | +0.005 | +3.9% | 0.125 | 0.131 | 0.123 | 95,603,619 | |
| 0.124 | +0.004 | +3.3% | 0.118 | 0.125 | 0.118 | 26,974,018 | |
| 0.12 | -0.002 | -1.5% | 0.122 | 0.124 | 0.118 | 38,323,188 | |
| 0.122 | +0.003 | +2.9% | 0.12 | 0.122 | 0.115 | 23,962,816 | |
| 0.118 | +0.001 | +0.5% | 0.12 | 0.125 | 0.116 | 29,024,388 | |
| 0.118 | -0.006 | -4.5% | 0.119 | 0.12 | 0.109 | 53,383,714 | |
| 0.123 | -0.005 | -4.2% | 0.13 | 0.13 | 0.119 | 37,008,448 | |
| 0.129 | +0.004 | +3.2% | 0.131 | 0.136 | 0.127 | 94,205,053 | |
| 0.125 | +0.007 | +5.8% | 0.12 | 0.125 | 0.115 | 50,157,250 | |
| 0.118 | +0.002 | +1.9% | 0.119 | 0.12 | 0.114 | 7,145,010 | |
| 0.116 | +0.001 | +0.9% | 0.115 | 0.118 | 0.11 | 10,438,092 | |
| 0.115 | +0.007 | +6.3% | 0.107 | 0.115 | 0.102 | 30,621,476 | |
| 0.108 | -0.012 | -10.0% | 0.12 | 0.122 | 0.105 | 29,170,819 | |
| 0.12 | -0.002 | -1.6% | 0.12 | 0.124 | 0.112 | 32,326,118 | |
| 0.122 | +0.003 | +2.5% | 0.123 | 0.124 | 0.114 | 22,280,603 | |
| 0.119 | +0.006 | +5.3% | 0.114 | 0.124 | 0.109 | 58,018,990 | |
| 0.113 | +0.009 | +8.2% | 0.105 | 0.114 | 0.10 | 57,639,115 | |
| 0.104 | +0.009 | +8.9% | 0.095 | 0.113 | 0.095 | 29,005,674 | |
| 0.096 | +0.003 | +3.1% | 0.098 | 0.098 | 0.094 | 5,469,384 | |
| 0.093 | +0.002 | +2.2% | 0.095 | 0.099 | 0.09 | 11,043,827 | |
| 0.091 | -0.003 | -3.1% | 0.089 | 0.095 | 0.087 | 7,266,494 | |
| 0.094 | 0.00 | -0.1% | 0.091 | 0.097 | 0.09 | 14,076,045 | |
| 0.094 | +0.001 | +0.9% | 0.095 | 0.098 | 0.091 | 6,869,734 | |
| 0.093 | -0.001 | -1.3% | 0.098 | 0.098 | 0.09 | 8,715,053 | |
| 0.094 | -0.002 | -1.7% | 0.099 | 0.099 | 0.09 | 6,047,357 | |
| 0.096 | -0.002 | -1.7% | 0.095 | 0.099 | 0.091 | 8,025,315 | |
| 0.098 | +0.011 | +13.3% | 0.086 | 0.103 | 0.086 | 23,565,008 | |
| 0.086 | -0.001 | -0.9% | 0.085 | 0.089 | 0.084 | 5,585,487 | |
| 0.087 | +0.002 | +2.5% | 0.088 | 0.088 | 0.082 | 5,657,948 | |
| 0.085 | -0.001 | -1.3% | 0.084 | 0.087 | 0.083 | 8,440,577 |
Splits
1 split · OSL:SOFTX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 50-for-1 | Split |
- Ticker
- Lang & Schwarz:A2JNDN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news
SoftOx Solutions AS: SoftOx attracts renowned inhaled antimicrobial expert Dr. Bruce Montgomery to lead Clinical Advisory Board ahead of Phase 2b
Sep 29, 2026
Closed 0.124 (+3.3%) on Sep 29, 2026
SoftOx Solutions AS: Half Year Report 2026
Sep 23, 2026
Closed 0.118 (-4.5%) on Sep 23, 2026
SoftOx Solutions AS: FIRST PATIENT DOSED IN SIS-03 PROOF-OF-CONCEPT PATIENT TRIAL
Aug 11, 2026
Closed 0.105 (+25.7%) on Aug 11, 2026
SoftOx Solutions AS: POSITIVE TOPLINE SAFETY DATA FROM SIS-03 DOSE-ESCALATION PHASE
Jun 26, 2026
Closed 0.113 (+2.9%) on Jun 26, 2026
SoftOx Solutions AS: First Quarter Report 2026
Jun 24, 2026
Closed 0.111 (+3.2%) on Jun 24, 2026
SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited
Jun 9, 2026
Closed 0.122 (+2.2%) on Jun 9, 2026
SoftOx Solutions AS: SIS-03 DOSE-ESCALATION PHASE COMPLETED AND INITIATION OF PROOF-OF-CONCEPT PHASE
Jun 8, 2026
Closed 0.12 (-4.2%) on Jun 8, 2026
SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY
Jun 5, 2026
Closed 0.125 (+1.5%) on Jun 5, 2026
SoftOx Solutions AS: Annual Report 2025
May 27, 2026
Closed 0.114 (-0.5%) on May 27, 2026
SoftOx Solutions AS: New Share Capital
Apr 21, 2026
Closed 0.111 (-2.6%) on Apr 21, 2026
SoftOx Solutions AS on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 17 in all · newest Sep 29, 2026 · oldest 2025
- Decks
- 12 decks · latest September 2025
Where SoftOx Solutions AS is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Oslo:SOFTX · Home listing | Oslo | Norway | NOK |
| LS Exchange:A2JNDN | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2JNDN · This page | Lang & Schwarz | Germany | EUR |
| Stuttgart:6FV | Stuttgart | Germany | EUR |
| Frankfurt:6FV | Frankfurt | Germany | EUR |
Valuation
Price/book 11.6× against a median of 2.1×: the highest of 11 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- 246.2M NOK
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 11.6×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| SoftOx Solutions AS · OSL:SOFTX | US$27.28M | US$25.25M | n/a | n/a | n/a | 11.6× | n/a | 0.0× | n/a |
| Entropy Neurodynamics Limited · ASX:ENP | US$28.12M | US$24.43M | n/a | n/a | n/a | 5.8× | n/a | 0.0× | n/a |
| Holy Stone Healthcare Co., Ltd. · TPEX:4194 | US$27.49M | US$25.08M | n/a | n/a | n/a | 7.3× | n/a | 0.0× | n/a |
| Edesa Biotech, Inc. · NASDAQ:EDSA | US$27.02M | US$16.72M | n/a | n/a | n/a | 3.1× | n/a | 0.0× | 0.47 |
| Amplia Therapeutics Ltd. · ASX:ATX | US$26.84M | US$8.63M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | n/a |
| Nasus Pharma Ltd. · AMEX:NSRX | US$26.82M | US$15.11M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 0.99 |
| Telomir Pharmaceuticals, Inc. · NASDAQ:TELO | US$26.82M | US$22.30M | n/a | n/a | n/a | 6.1× | n/a | 0.0× | 1.74 |
| BriaCell Therapeutics Corp · TSX:BCT | US$26.79M | US$6.25M | n/a | n/a | n/a | 1.7× | n/a | 0.0× | 1.07 |
| Alterity Therapeutics Ltd. · ASX:ATH | US$26.76M | US$2.18M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | n/a |
| EyePoint, Inc. · NASDAQ:EYPT | US$26.65M | −US$72.44M | n/a | −28.1× | n/a | 0.3× | n/a | 0.2× | 1.36 |
| Aprogen, Inc · KRX:007460 | US$26.64M | US$21.31M | n/a | 0.2× | n/a | 0.6× | −60.1% | 0.6× | n/a |
| Median of the others | US$26.82M | US$15.92M | −13.9× | 2.1× | −60.1% | 0.0× | 1.07 |
Team and board
Officers
| Officer | Role |
|---|---|
| Thomas Bjarnsholt | CEO/Chief Scientific Officer |
| Ingrid Juven | CFO |
| Charlotte Pinholt | Head of CMC |
Board
| Director | Role |
|---|---|
| Ulrik Spork | Chairman of the Board |
| Adrian Bignami | Non-Executive Director |
| Christian Vinding Thomsen | Vice Chairman |
| Tore Duvold | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Jun 20, 2024 · Before open | +2.2% |
| Q4 2023 | Mar 27, 2024 · Before open | −45.4% |
| Q3 2021 | Nov 17, 2021 | −3.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2025) | Investor deck | 32 slides | September 2025 |
| Investor Presentation (August 2024) | Investor deck | 19 slides | August 2024 |
| Investor Presentation (April 2024) | Investor deck | 26 slides | Apr 18, 2024 |
| Investor Presentation (March 2024) | Investor deck | 23 slides | March 2024 |
| Investor Presentation (January 2024) | Investor deck | 31 slides | Jan 8, 2024 |
| Investor Presentation (March 2023) | Investor deck | 39 slides | March 2023 |
| DNB Healthcare Conference 2022 | Conference | 20 slides | Dec 15, 2022 |
| Q3 2022 Earnings Presentation | Earnings | 34 slides | Oct 26, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 40 slides | Aug 15, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 25 slides | Apr 28, 2022 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (November 2021) | Investor day | 77 slides | Nov 17, 2021 |
| Investor Presentation (December 2019) | Investor deck | 28 slides | December 2019 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of shares Announced: NOK 0.13 a share Buyers: Long State (46 380 523 shares) Use of proceeds: To secure funding of SoftOx | Jun 9, 2026 | |
| Private placement of shares Closed: NOK 7.2M raised Buyers: Long State Investments Limited (private placement of NOK 7 200 000 under the financing facility) | Apr 21, 2026 | US$770,995 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in NOK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 7.91M | 6.98M | 7.11M | 7.90M | 9.84M | 4.10M | 4.32M | 1.00K | 101.0K |
| Selling, general and administrative | 4.98M | 7.79M | 26.4M | 21.1M | 18.9M | 11.2M | 8.18M | 4.08M | 2.94M | |
| Operating income | -11.4M | -32.5M | -32.6M | -91.1M | -86.1M | -51.4M | -21.9M | -17.3M | -13.2M | -9.01M |
| Depreciation and amortization | 3.19M | 5.37M | 7.48M | 3.90M | 3.78M | 2.70M | 1.70M | 1.12M | 969.0K | |
| EBITDA | -8.18M | -27.1M | -25.2M | -87.2M | -82.3M | -48.7M | -20.2M | -16.2M | -12.2M | |
| Interest expense | 9.17M | 8.93M | 2.24M | 87.8K | 0 | 146.4K | 502 | 0 | 0 | |
| Income before tax | -10.8M | -50.5M | -42.1M | -93.7M | -86.3M | -49.7M | -22.2M | -17.5M | -13.2M | -8.91M |
| Income tax | -20.9M | -12.3M | -5.84M | -4.53M | ||||||
| Net income | -10.8M | -42.9M | -39.4M | -71.1M | -86.3M | -37.4M | -16.3M | -12.9M | -9.41M | -6.22M |
| Earnings per share, basic | -0.00 | -0.02 | -0.95 | -6.88 | -8.34 | -4.49 | -2.11 | -3.42 | -2.48 | -1.65 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19.8M | 10.5M | 7.65M | 6.91M | 57.0M | 34.8M | 76.0M | 1.24M | 17.1M | 302.0K |
| Receivables | 7.79M | 8.67M | 8.96M | 5.66M | 6.18M | |||||
| Inventory | 0 | 0 | 0 | 0 | 195.8K | 2.97M | ||||
| Current assets | 19.8M | 10.5M | 8.60M | 14.7M | 65.9M | 46.7M | 81.7M | 7.42M | 19.9M | 2.15M |
| Property, plant and equipment | 0 | 647.5K | 3.89M | 3.49M | 3.91M | 241.7K | 326.7K | 471.7K | 585.6K | |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 123.5K | ||||
| Total assets | 33.9M | 121.1M | 97.2M | 77.8M | 107.2M | 87.3M | 105.0M | 23.4M | 31.0M | 8.86M |
| Accounts payable | 997.0K | 6.38M | 20.9M | 11.3M | 6.03M | 5.80M | 11.0M | 4.41M | ||
| Current liabilities | 11.0M | 26.0M | 49.3M | 20.8M | 18.0M | 11.1M | 18.4M | 8.98M | 4.19M | 6.38M |
| Long-term debt | 0 | 0 | 45.6M | 41.1M | 350.0K | |||||
| Total liabilities | 11.0M | 26.0M | 94.9M | 61.8M | 18.3M | 11.1M | 18.5M | 8.98M | 4.19M | 6.38M |
| Shareholders' equity | 23.0M | 95.2M | 2.37M | 16.0M | 88.8M | 76.2M | 86.5M | 14.4M | 26.8M | 2.48M |
| Shares outstanding | 2.39B | 1.95B | 41.5M | 10.3M | 10.3M | 8.33M | 7.75M | 3.78M | 3.80M | 3.77M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -18.9M | 32.6M | 756.7K | -85.9M | -72.6M | -60.4M | -10.6M | -14.9M | -15.3M |
| Capital spending | 0 | -19.8M | -7.61M | -4.85M | -4.60M | -7.67M | -3.20M | -1.44M | -1.49M |
| Free cash flow | -18.9M | 12.7M | -6.85M | -90.8M | -72.6M | -68.1M | -13.8M | -14.9M | -16.8M |
| Cash from investing | -19.8M | -7.61M | -4.85M | -4.60M | -7.67M | -3.20M | -1.44M | -1.49M | |
| Cash from financing | -9.86M | 7.60M | 40.7M | 99.3M | 26.9M | 88.5M | 521.6K | 33.6M | |
| Share buybacks | 35.7M | 3.08M | 0 | 89.0M | 27.1M | 88.4M | 600.0K | 33.7M | |
| Change in cash | 9.28M | 2.86M | 747.6K | -50.1M | 22.2M | -41.2M | 74.8M | -15.9M | 16.8M |
Cap table
Built by 6ix from SoftOx Solutions AS’ releases · as of Jun 9, 2026
- Common shares
- 2,659,955,723
- Fully diluted
- 2,659,955,723
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 2,659,955,723 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,659,955,723 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Adrian Bignami | Non-Executive Director · Since at least Nov 5, 2026 |
| Charlotte Pinholt | Head of CMC · Since at least Nov 14, 2025 |
| Christian Vinding Thomsen | Vice Chairman · Since at least Nov 5, 2026 |
| Ingrid Juven | CFO · Since at least Jun 9, 2026 |
| Thomas Bjarnsholt | CEO/Chief Scientific Officer · Since at least Sep 29, 2026 |
| Tore Duvold | Non-Executive Director · Since at least Nov 5, 2026 |
| Ulrik Spork | Chairman of the Board · Since at least Aug 11, 2026 |
Log in to ask 6ix AI your own questions about SoftOx Solutions AS.